Corzall-PE Interactions
There are 473 drugs known to interact with Corzall-PE (carbetapentane / dexchlorpheniramine / phenylephrine), along with 8 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 37 are major, 433 are moderate, and 3 are minor.
- View all 473 medications that may interact with Corzall-PE
- View Corzall-PE alcohol/food interactions (2)
- View Corzall-PE disease interactions (8)
Most frequently checked interactions
View interaction reports for Corzall-PE (carbetapentane / dexchlorpheniramine / phenylephrine) and the medicines listed below.
- acetaminophen / codeine
- acetaminophen / hydrocodone
- albuterol / ipratropium
- azelastine nasal
- betamethasone
- candesartan
- carvedilol
- cefdinir
- cephalexin
- ciprofloxacin
- clarithromycin
- Claritin (loratadine)
- clonidine
- codeine / promethazine
- Crestor (rosuvastatin)
- dextromethorphan
- diphenhydramine
- Elestat (epinastine ophthalmic)
- escitalopram
- finasteride
- Flovent (fluticasone)
- guaifenesin
- Hemorrhoidal HC (hydrocortisone topical)
- hydroxyzine
- L-Arginine (arginine)
- lisinopril
- meclizine
- MethylPREDNISolone Dose Pack (methylprednisolone)
- montelukast
- Nexium 24HR (esomeprazole)
Corzall-PE alcohol/food interactions
There are 2 alcohol/food interactions with Corzall-PE (carbetapentane / dexchlorpheniramine / phenylephrine).
Corzall-PE disease interactions
There are 8 disease interactions with Corzall-PE (carbetapentane / dexchlorpheniramine / phenylephrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- BPH
- diabetes
- glaucoma
More about Corzall-PE (carbetapentane / dexchlorpheniramine / phenylephrine)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.